Concepedia

Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society

Aditya Kapoor, Ulhas M. Pandurangi, Vanita Arora, Anoop K. Gupta, Aparna Jaswal, Ashish Nabar, Ajay Naik, Nitish Naik, Narayanan Namboodiri, Amit Vora,

Indian Pacing and Electrophysiology Journal · 2020 · 96 citations · 4 references

DOIFull text

Open access

Concepts

References

4

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 5K citations · Full text

, , +10

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Xueting Yao, Fei Ye, Miao Zhang et al. · Clinical Infectious Diseases · 2020 · 2.8K citations · Full text

, , +17

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Christian Devaux, Jean‐Marc Rolain, Philippe Colson et al. · International Journal of Antimicrobial Agents · 2020 · 1.1K citations · Full text

, , +14

Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)

John R. Giudicessi, Peter A. Noseworthy, Paul A. Friedman et al. · Mayo Clinic Proceedings · 2020 · 404 citations · Full text

, , +15